Antiviral treatment for hospitalized influenza pediatric patients declining
From 2017-2018, antiviral treatment of hospitalized children with influenza ranged from 70%-86%. In the 2023-2024 season, it was less than 60%.
Food Insecurity and the Dangers of Infant Formula Dilution
New phase 3 data of JNJ-2113 for plaque psoriasis in patients aged 12 years, older
Once-daily icotrokinra versus placebo demonstrated clinically significant skin clearance in those with moderate-to-severe plaque psoriasis.
Demystifying Infant Formula
Prenatally substance-exposed infants and SUID outcomes
Stephanie Anne Deutsch, MD, MS, MSCR, FAAP, joined us to discuss a new study that highlighted SUID among infants who were prenatally substance exposed.
Awareness for epilepsy surgery among drug-resistant pediatric patients
H. Westley Phillips, MD, explains why awareness and availability of epilepsy surgery is important for pediatric providers among drug-resistant epilepsy patients.
